Veracyte Inc (VCYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 239,087 | 274,079 | 235,915 | 209,188 | 216,454 |
| Marketable Securities | 50,354 | N/A | N/A | N/A | N/A |
| Receivables | 46,525 | 48,807 | 50,304 | 46,665 | 40,378 |
| Inventories | 21,750 | 20,364 | 19,258 | 18,328 | 16,128 |
| TOTAL | $372,267 | $356,854 | $321,106 | $290,418 | $285,621 |
| Non-Current Assets | |||||
| PPE Net | 22,953 | 21,194 | 22,291 | 21,566 | 20,584 |
| Intangibles | 848,101 | 870,990 | 864,639 | 870,201 | 791,577 |
| Other Non-Current Assets | 56,714 | 25,983 | 26,291 | 17,888 | 17,124 |
| TOTAL | $927,768 | $918,167 | $913,221 | $909,655 | $829,285 |
| Total Assets | $1,300,035 | $1,275,021 | $1,234,327 | $1,200,073 | $1,114,906 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,634 | 9,670 | 12,084 | 12,152 | 12,943 |
| Accrued Expenses | 43,826 | 43,872 | 43,455 | 30,293 | 38,427 |
| Other current liabilities | 17,000 | 7,444 | 7,420 | 7,023 | 2,758 |
| TOTAL | $78,633 | $70,313 | $72,339 | $58,052 | $61,241 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,673 | 2,033 | 2,195 | 2,602 | 2,008 |
| Other Non-Current Liabilities | 44,209 | 27,196 | 27,982 | 22,032 | 8,829 |
| TOTAL | $45,436 | $28,666 | $29,465 | $23,372 | $9,563 |
| Total Liabilities | $124,069 | $98,979 | $101,804 | $81,424 | $70,804 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 77,945 | 77,500 | 76,812 | 76,448 | 75,068 |
| Common Shares | 78 | 77 | 77 | 76 | 73 |
| Retained earnings | -443,983 | -449,096 | -464,251 | -469,985 | -468,121 |
| Other shareholders' equity | -36,090 | -21,282 | -30,610 | -28,907 | -24,018 |
| TOTAL | $1,175,966 | $1,176,042 | $1,132,523 | $1,118,649 | $1,044,102 |
| Total Liabilities And Equity | $1,300,035 | $1,275,021 | $1,234,327 | $1,200,073 | $1,114,906 |